Feasibility and Outcomes of Repeat Percutaneous Edge-to-Edge Mitral Valve Repair Procedures in Patients at High Risk for Surgery.
暂无分享,去创建一个
S. Buccheri | D. Capodanno | C. Tamburino | M. Barbanti | S. Immé | P. Capranzano | S. Scandura | C. Grasso | M. D. Di Salvo | A. Popolo Rubbio | S. Mangiafico | G. Castania
[1] S. Buccheri,et al. Strategies and Outcomes of Repeat Mitral Valve Interventions after Failed MitraClip Therapy , 2017, Cardiology.
[2] D. Adams,et al. Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part€2: Endpoint Definitions , 2017 .
[3] K. Kuck,et al. Repeat MitraClip Therapy for Significant Recurrent Mitral Regurgitation in High Surgical Risk Patients: Impact of Loss of Leaflet Insertion. , 2015, JACC. Cardiovascular interventions.
[4] G. Filippatos,et al. Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 2: Endpoint Definitions: A Consensus Document From the Mitral Valve Academic Research Consortium. , 2015, Journal of the American College of Cardiology.
[5] D. Capodanno,et al. One- and twelve-month safety and efficacy outcomes of patients undergoing edge-to-edge percutaneous mitral valve repair (from the GRASP Registry). , 2013, The American journal of cardiology.